Short Term Cancer Risk

Size: px
Start display at page:

Download "Short Term Cancer Risk"

Transcription

1 in a Cohort of 2312 Women with High Risk Breast Lesions Kubat E 1, Puligandla B 2, Collins L 3, Jiang SF 4, Callahan M 5, Kutner S 6, Habel L 4, Shim V 1 1 Surgery, Kaiser Permanente, Oakland, CA; 2 Pathology, Kaiser Permanente, Oakland, CA; 3 Beth Israel Deaconess Medical Center, Boston, MA; 4 Division of Research, Kaiser Permanente, Oakland, CA 5 Genetics, Kaiser Permanente, Oakland, CA; 6 Surgery, Kaiser Permanente, Santa Theresa, CA Eric Kubat M.D. PGY 2 Kaiser Permanente, Oakland CA Dept. of Surgery UCSF East Bay Background Increased use of mammographic screening has resulted in a growing number of women diagnosed with high risk breast lesions. No clear guidelines for treatment or follow up Reliable estimates of subsequent breast cancer risk are needed to develop these guidelines and assist patients and their physicians in decisions regarding risk reduction reduction strategies.

2 Aim To estimate incidence rates of subsequent breast cancer among women diagnosed in the community setting with a high risk breast lesion. Atypical ductal hyperplasia (ADH) Lobular hyperplasia (ALH) Lobular carcinoma in situ (LCIS) Methods Study population: Kaiser Permanente health plan members Community based diagnosis ( ) Atypical ductal hyperplasia (ADH) Lobular hyperplasia (ALH) Lobular carcinoma in situ (LCIS) 2312 eligible women ADH (n=1599) ALH (n=698) LCIS (n=226)

3 Methods Exclusion criteria Documented history of breast cancer Diagnosis based on fine needle needle aspirate No available pathology report Documented breast cancer within 6 months after diagnosis of high risk risk breast lesion Methods Follow up Pathology to confirm diagnosis Laterality, indication, histopathologic features. Cohort followed until one criterion met Diagnosis of a subsequent breast cancer invasive ductal (IDC), invasive lobular (ILC), and/or ductal carcinoma in situ (DCIS) End of membership December 2005

4 Methods Analysis Cohort of 2312 Women with High-Risk Breast Lesions Cumulative incidence curves were generated and Cox regression analyses were used to generate Relative Risk ratios. Patient Characteristics Characteristics* Full Cohort Cancer Cases Percent Age Years Age < Age Age Age Age Age Diagnosis Year Histology of High Risk Lesion ALH only ADH only LCIS only ALH+ADH ALH+LCIS ADH+LCIS ADH+AH, NOS ALH+ADH+LCIS Other Cancer Cases Full Cohort Cancer Cases 36 months 32 months *Diagnosis of High Risk Breast Lesion

5 ADH Laterality of High-Risk Lesion and Subsequent Cancer Invasive Ductal (N) Invasive Lobular (N) DCIS (N) Total (N%) Ipsilateral (58.2%) Contralateral (41.8%) 67 ALH Ipsilateral (58.3%) Contralateral (41.7%) 36 LCIS Ipsilateral (42.9%) Contralateral (52.1%) 21

6

7 Relative Risk of Any Cancer (Adjusting for Age) Total (N) Cases (N) Relative Risk 95% CI P Value ADH Reference 1 ALH LCIS Relative Risk of Invasive Cancer (Adjusting for Age) Total (N) Cases (N) Relative Risk 95% CI P Value ADH Reference 1.0 ALH LCIS

8 Results 123 women with High Risk lesions developed DCIS or invasive breast cancer. ADH / ALH, approximately 60% of cancers were in the ipsilateral breast LCIS approximately 40% of cancers were ipsilateral. Results Women 50+ years (5 year outcomes) Invasive Ductal Invasive Lobular Carcinoma Carcinoma LCIS 8% 2% ALH 4% 1.5% ADH 4% <1.5% ALH + ADH 7% 1%

9 Results Adjusting for age, risk of subsequent cancer among women with LCIS was approximately 2x that for women with ADH. Risk of subsequent cancer was similar among women with ADH or ALH. Results Patients aged years with atypical hyperplasia (ADH or ALH) have approximately 3x the risk of breast cancer at 5 years compared to similarly aged women in the general population (based on estimates from the Gail model).

10 Limitations Diagnoses were not confirmed by a standardized re review of slides. Number of cancers, especially when stratified by histology, was small and estimates are imprecise. Short term term follow up (<10 yrs, median 3.5 yrs) - Time to cancer is often protracted. Conclusions In this population of women diagnosed with high risk lesions, risk of subsequent invasive breast cancer was significant and varied by age and lesion histology Similar findings to prior studies

11 Acknowledgements Veronica Shim Laurel Habel Balaram Puligandla Laura Collins Sheng Fang Jiang Mary Callahan Susan Kutner Kaiser Foundation Research Institute

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Giannakeas V, Sopik V, Narod SA. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy. JAMA Netw Open. 2018;1(4):e181100.

More information

LOBULAR CARCINOMA IN SITU: WHAT DOES IT MEAN? THE SURGEON'S PERSPECTIVE

LOBULAR CARCINOMA IN SITU: WHAT DOES IT MEAN? THE SURGEON'S PERSPECTIVE : WHAT DOES IT MEAN? THE SURGEON'S PERSPECTIVE Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University of Washington Joint Member, Fred Hutchinson Cancer

More information

Columnar Cell Lesions

Columnar Cell Lesions Columnar Cell Lesions Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Question? Columnar cell lesions are: a) Annoying lesions

More information

Pathology of Lobular & Ductal Preneoplasia. Syed A Hoda, MD Weill-Cornell, New York, NY

Pathology of Lobular & Ductal Preneoplasia. Syed A Hoda, MD Weill-Cornell, New York, NY Pathology of Lobular & Ductal Preneoplasia Syed A Hoda, MD Weill-Cornell, New York, NY Proliferative Epithelial Changes in Breast A wide range of proliferative epithelial changes occur in the breast There

More information

Ductal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA

Ductal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Ductal Carcinoma in Situ Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Definition of DCIS WHO 2012 A neoplastic proliferation

More information

The Hot Topic for today is a biopsy from a 58-year-old woman who had worrisome mammographic calcifications on screening.

The Hot Topic for today is a biopsy from a 58-year-old woman who had worrisome mammographic calcifications on screening. The Hot Topic for today is a biopsy from a 58-year-old woman who had worrisome mammographic calcifications on screening. 1 My name is Dan Visscher; I am a consultant in the Division of Anatomic Pathology

More information

04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES

04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES Pathology Perspectives of High Risk Breast Lesions Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head Director of Clinical Trials, Research and Development The University of Texas MD

More information

Atypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy

Atypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy Atypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy Breast Cancer is the most common cancer diagnosed in women in the United

More information

Columnar Cell Lesions and Flat Epithelial Atypia

Columnar Cell Lesions and Flat Epithelial Atypia Columnar Cell Lesions and Flat Epithelial Atypia Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA Terminology for Columnar Cell

More information

Columnar Cell Lesions. Columnar Cell Lesions and Flat Epithelial Atypia

Columnar Cell Lesions. Columnar Cell Lesions and Flat Epithelial Atypia Columnar Cell Lesions and Stuart J. Schnitt, M.D. Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA, USA Columnar Cell Lesions Lesions characterized by columnar epithelial cells

More information

Treatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea

Treatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea Treatment options for the precancerous Atypical Breast lesions Prof. YOUNG-JIN SUH The Catholic University of Korea Not so benign lesions? Imaging abnormalities(10% recall) lead to diagnostic evaluation,

More information

3/27/2017. Disclosure of Relevant Financial Relationships. Papilloma???

3/27/2017. Disclosure of Relevant Financial Relationships. Papilloma??? Management of Papillary Lesions Diagnosed at Rad Path Concordant Core Biopsy (CNB) Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to

More information

Cytyc Corporation - Case Presentation Archive - March 2002

Cytyc Corporation - Case Presentation Archive - March 2002 FirstCyte Ductal Lavage History: 68 Year Old Female Gail Index: Unknown Clinical History: Negative Mammogram in 1995 6 yrs. later presents with bloody nipple discharge Subsequent suspicious mammogram Suspicious

More information

Evaluation & Management of PowerPoint Cover Title. the High Risk Population. High Risk Clinic

Evaluation & Management of PowerPoint Cover Title. the High Risk Population. High Risk Clinic Evaluation & Management of PowerPoint Cover Title the High Risk Population High Risk Clinic Subtitle Joanna Would Springman, Go Here PA-C Assessment Genetics Known genetic mutation Family history with

More information

Surgical Pathology Issues of Practical Importance

Surgical Pathology Issues of Practical Importance Surgical Pathology Issues of Practical Importance Anne Moore, MD Medical Oncology Syed Hoda, MD Surgical Pathology The pathologist is central to the team approach needed to manage the patient with breast

More information

Current Status of Supplementary Screening With Breast Ultrasound

Current Status of Supplementary Screening With Breast Ultrasound Current Status of Supplementary Screening With Breast Ultrasound Stephen A. Feig, M.D., FACR Fong and Jean Tsai Professor of Women s Imaging Department of Radiologic Sciences University of California,

More information

Evaluations & CE Credits

Evaluations & CE Credits Evaluations & CE Credits Nursing Contact Hours, CME and CHES credits are available. Please visit www.phlive.org to fill out your evaluation and complete the post-test. 1 Breast Density and Breast Cancer

More information

Histological Type. Morphological and Molecular Typing of breast Cancer. Nottingham Tenovus Primary Breast Cancer Study. Survival (%) Ian Ellis

Histological Type. Morphological and Molecular Typing of breast Cancer. Nottingham Tenovus Primary Breast Cancer Study. Survival (%) Ian Ellis Morphological and Molecular Typing of breast Cancer Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology, Nottingham University Hospitals NHS Trust Histological Type

More information

Disclosures. Premalignant Lesions of the Breast: What Clinicians Want and Why. NY Times: Prone to Error: Earliest Steps to Find Cancer.

Disclosures. Premalignant Lesions of the Breast: What Clinicians Want and Why. NY Times: Prone to Error: Earliest Steps to Find Cancer. Disclosures Premalignant Lesions of the Breast: What Clinicians Want and Why I have nothing to disclose Rick Baehner, MD Assistant Professor, UCSF Pathology NY Times: Prone to Error: Earliest Steps to

More information

Benign Breast Disease and Breast Cancer Risk

Benign Breast Disease and Breast Cancer Risk Benign Breast Disease and Breast Cancer Risk Jean F. Simpson, M.D. Vanderbilt University Nashville, Tennessee December 1, 2011 Nashville Nashville Lebanon 1 Cedars of Lebanon State Park The American University

More information

Jeddah Breast Cancer Pilot Screening Program, KSA

Jeddah Breast Cancer Pilot Screening Program, KSA Jeddah Breast Cancer Pilot Screening Program, KSA 7 th Global Summit on Cancer Therapy, Oct 5-7, 2015 Dubai, Crown Plaza Hotel Muna Baslaim, MD Consultant Surgeon Head of the Breast Unit, King Fahd General

More information

Breast Cancer Screening Clinical Practice Guideline. Kaiser Permanente National Breast Cancer Screening Guideline Development Team

Breast Cancer Screening Clinical Practice Guideline. Kaiser Permanente National Breast Cancer Screening Guideline Development Team NATIONAL CLINICAL PRACTICE GUIDELINE Breast Cancer Screening Clinical Practice Guideline Kaiser Permanente National Breast Cancer Screening Guideline Development Team This guideline is informational only.

More information

Excisional biopsy or long term follow-up results in breast high-risk lesions diagnosed at core needle biopsy

Excisional biopsy or long term follow-up results in breast high-risk lesions diagnosed at core needle biopsy Excisional biopsy or long term follow-up results in breast high-risk lesions diagnosed at core needle biopsy Poster No.: C-2515 Congress: ECR 2015 Type: Authors: Scientific Exhibit Ö. S. Okcu 1, A. Oktay

More information

BreastScreen Victoria Annual Statistical Report

BreastScreen Victoria Annual Statistical Report BreastScreen Victoria Annual Statistical Report 2010 BREASTSCREEN VICTORIA: ANNUAL STATISTICAL REPORT, 2010 Produced by: BreastScreen Victoria Coordination Unit Level 1, 31 Pelham Street, Carlton South

More information

BreastScreen Victoria Annual Statistical Report

BreastScreen Victoria Annual Statistical Report BreastScreen Victoria Annual Statistical Report 29 BREASTSCREEN VICTORIA: ANNUAL STATISTICAL REPORT, 29 Produced by: BreastScreen Victoria Coordination Unit Level, 3 Pelham Street, Carlton South Victoria

More information

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES Papillomas. Papillomas are composed of multiple branching fibrovascular cores, each having a connective tissue axis lined by luminal and myoepithelial cells ( Fig. 23-11 ). Growth occurs within a dilated

More information

K. M. Sorensen Utah State University, Logan, Utah

K. M. Sorensen Utah State University, Logan, Utah K. M. Sorensen Utah State University, Logan, Utah T. E. Doyle, B. D. Borget, M. Cervantes, J. A. Chappell, B. J. Curtis, M. A. Grover, J. E. Roring, J. E. Stiles, and L. A. Thompson Utah Valley University,

More information

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases

More information

Breast Cancer. Saima Saeed MD

Breast Cancer. Saima Saeed MD Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast

More information

Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care

Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:

More information

Breast Lesion Excision System-Intact (BLES): A Stereotactic Method of Biopsy of Suspicius Non-Palpable Mammographic Lesions.

Breast Lesion Excision System-Intact (BLES): A Stereotactic Method of Biopsy of Suspicius Non-Palpable Mammographic Lesions. Breast Lesion Excision System-Intact (BLES): A Stereotactic Method of Biopsy of Suspicius Non-Palpable Mammographic Lesions. Poster No.: C-1595 Congress: ECR 2014 Type: Authors: Scientific Exhibit I. Georgiou

More information

ANCO s 2011 San Antonio Breast Cancer Symposium Highlights. Michael Alvarado, M.D. Disclosure

ANCO s 2011 San Antonio Breast Cancer Symposium Highlights. Michael Alvarado, M.D. Disclosure ANCO s 2011 San Antonio Breast Cancer Symposium Highlights Michael Alvarado, M.D. FACS Assistant Professor of Surgery UCSF Michael Alvarado, M.D. Disclosure Advisory Board Member Genomic Health DCIS Study

More information

Imaging Surveillance in Women with a History of Treated Breast Cancer. Wei Tse Yang, M.D.

Imaging Surveillance in Women with a History of Treated Breast Cancer. Wei Tse Yang, M.D. Imaging Surveillance in Women with a History of Treated Breast Cancer Wei Tse Yang, M.D. Breast Cancer 1. Extent 2. Response 3. Recurrence Surveillance Breast Cancer 1. Extent 2. Response Surveillance

More information

Contralateral Prophylactic Mastectomy with Immediate Reconstruction: Added Benefits, Added Risks

Contralateral Prophylactic Mastectomy with Immediate Reconstruction: Added Benefits, Added Risks Contralateral Prophylactic Mastectomy with Immediate Reconstruction: Added Benefits, Added Risks Grant W. Carlson Wadley R. Glenn Professor of Surgery Divisions of Plastic Surgery & Surgical Oncology Emory

More information

Controversies and Problematic Issues in Core Needle Biopsies (To excise or not to excise)

Controversies and Problematic Issues in Core Needle Biopsies (To excise or not to excise) Controversies and Problematic Issues in Core Needle Biopsies (To excise or not to excise) Laura C. Collins, M.D. Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Schematic Representation

More information

Greater Sacramento Chapter Oncology Nursing Society Newsletter

Greater Sacramento Chapter Oncology Nursing Society Newsletter W I N T E R 2 0 1 4 / 2 0 1 5 Greater Sacramento Chapter Oncology Nursing Society Newsletter Hello GSCONS Membership, It is that time of year for our chapter to get ready for elections to the board. We

More information

IBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina

IBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina Preoperative diagnosis and treatment planning in breast cancer The pathologist s perspective L. Mazzucchelli Istituto Cantonale di Patologia Locarno, Switzerland IBCM 2, 23-25 April 2009, Sarajevo, Bosnia

More information

Mammography and Other Screening Tests. for Breast Problems

Mammography and Other Screening Tests. for Breast Problems 301.681.3400 OBGYNCWC.COM Mammography and Other Screening Tests What is a screening test? for Breast Problems A screening test is used to find diseases, such as cancer, in people who do not have signs

More information

Proliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London

Proliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London Proliferative Epithelial lesions of the Breast Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London Amman, November2013 Proliferative Epithelial Lesions of the Breast Usual type

More information

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration

More information

BI-RADS CATEGORIZATION AND BREAST BIOPSY categorization in the selection of appropriate breast biopsy technique is also discussed. Patients and method

BI-RADS CATEGORIZATION AND BREAST BIOPSY categorization in the selection of appropriate breast biopsy technique is also discussed. Patients and method Original Article Positive Predictive Value of BI-RADS Categorization in an Asian Population Yah-Yuen Tan, Siew-Bock Wee, Mona P.C. Tan and Bee-Kiang Chong, 1 Departments of General Surgery and 1Diagnostic

More information

On the Clinical Importance of Benign Breast Disease: Causal Intermediary or Susceptibility Marker? Laura Reimers Iadeluca

On the Clinical Importance of Benign Breast Disease: Causal Intermediary or Susceptibility Marker? Laura Reimers Iadeluca On the Clinical Importance of Benign Breast Disease: Causal Intermediary or Susceptibility Marker? Laura Reimers Iadeluca Submitted in partial fulfillment of the requirements for the degree of Doctor of

More information

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research NCCN/JCCNB Seminar in Japan April 15, 2012 Case study 1 Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research Present illness: A 50y.o.premenopausal

More information

Breast Pathology. Breast Development

Breast Pathology. Breast Development Breast Pathology Lecturer: Hanina Hibshoosh, M.D. Reading: Kumar, Cotran, Robbins, Basic Pathology, 6th Edition, pages 623-635 Breast Development 5th week - thickening of the epidermis - milk line 5th

More information

Carcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS

Carcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS Carcinoma mammario: le istologie non frequenti Valentina Guarneri Università di Padova IOV-IRCCS Histological diversity of breast adenocarcinomas Different histological types are defined according to specific

More information

Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer JAMA. 2008;299(18):

Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer JAMA. 2008;299(18): ORIGINAL CONTRIBUTION Combined Screening With Ultrasound and vs Alone in Women at Elevated Risk of Breast Cancer Wendie A. Berg, MD, PhD Jeffrey D. Blume, PhD Jean B. Cormack, PhD Ellen B. Mendelson, MD

More information

Prophylactic Mastectomy

Prophylactic Mastectomy Prophylactic Mastectomy Policy Number: Original Effective Date: MM.06.010 01/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 12/01/2013 Section: Surgery Place(s) of Service:

More information

Flat Epithelial Atypia

Flat Epithelial Atypia Flat Epithelial Atypia Richard Owings, M.D. University of Arkansas for Medical Sciences Department of Pathology Flat epithelial atypia can be a difficult lesion May be a subtle diagnosis Lots of changes

More information

ACRIN 6666 Therapeutic Surgery Form

ACRIN 6666 Therapeutic Surgery Form S1 ACRIN 6666 Therapeutic Surgery Form 6666 Instructions: Complete a separate S1 form for each separate area of each breast excised with the intent to treat a cancer (e.g. each lumpectomy or mastectomy).

More information

6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies

6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies Outline of Talk Lobular Breast Cancer: Common Problems in Diagnosing LCIS in Core Biopsies Definition of lobular differentiation Variants of LCIS that: carry risk for unsampled invasive cancer mimic DCIS

More information

Atypical proliferative lesions diagnosed on core biopsy - 6 year review

Atypical proliferative lesions diagnosed on core biopsy - 6 year review Atypical proliferative lesions diagnosed on core biopsy - 6 year review Dr Angela Harris, Dr Julie Weigner & Dr Ricardo Vilain NSW Health Pathology Pathology North, Hunter Anatomical Pathology & Cytology

More information

Promise of a beautiful day

Promise of a beautiful day Promise of a beautiful day Ductal carcinoma in Situ Lobular Carcinoma in Situ Natural History Manosmed Tartous Oct 2009 Gérard ABADJIAN MD Pathology Department Hôtel-Dieu de France. Associate Professor

More information

Disclosures 5/27/2012. Outline of Talk. Outline of Talk. When Is LCIS Clinically Significant? Classic LCIS. Classic LCIS

Disclosures 5/27/2012. Outline of Talk. Outline of Talk. When Is LCIS Clinically Significant? Classic LCIS. Classic LCIS When Is LCIS Clinically Significant? Disclosures I have nothing to disclose Yunn-Yi Chen, MD, PhD Professor Outline of Talk Outline of Talk Classic LCIS Classic LCIS Definition of lobular differentiation

More information

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration

More information

Morphological and Molecular Typing of breast Cancer

Morphological and Molecular Typing of breast Cancer Morphological and Molecular Typing of breast Cancer Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology, Nottingham University Hospitals NHS Trust Histological

More information

Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB)

Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB) Original article Annals of Oncology 14: 450 454, 2003 DOI: 10.1093/annonc/mdh088 Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB)

More information

Proliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease

Proliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease Proliferative Breast Disease: implications of core biopsy diagnosis Jean F. Simpson, M.D. Breast Pathology Consultants, Inc. Nashville, TN Proliferative Breast Disease Must be interpreted in clinical and

More information

Diagnostic benefits of ultrasound-guided. CNB) versus mammograph-guided biopsy for suspicious microcalcifications. without definite breast mass

Diagnostic benefits of ultrasound-guided. CNB) versus mammograph-guided biopsy for suspicious microcalcifications. without definite breast mass Volume 118 No. 19 2018, 531-543 ISSN: 1311-8080 (printed version); ISSN: 1314-3395 (on-line version) url: http://www.ijpam.eu ijpam.eu Diagnostic benefits of ultrasound-guided biopsy versus mammography-guided

More information

OBSERVATIONS AND RESULTS. Gradewise

OBSERVATIONS AND RESULTS. Gradewise OBSERVATIONS AND RESULTS Observations: Table 7. Gradewise Grade II 2 Grade III Total 8 % % + % 31% 17 21% 3 38% 69% 63 79% 62% 1 8 1 8 1 Out of 24 patients 168(7%) patients had been diagnosedd with Grade

More information

Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008

Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008 Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008 Breast Cancer Most common cancer in American women 180,000 new cases per year Second most common cause of cancer death 44,000

More information

DIAGNOSIS. Biopsy, Pathology and Subtypes. Knowledge Summary

DIAGNOSIS. Biopsy, Pathology and Subtypes. Knowledge Summary DIAGNOSIS Biopsy, Pathology and Subtypes Knowledge Summary DIAGNOSIS Biopsy, Pathology and Subtypes INTRODUCTION The success of an effective breast health care program is directly related to the availability

More information

The New England Journal of Medicine RADIAL SCARS IN BENIGN BREAST-BIOPSY SPECIMENS AND THE RISK OF BREAST CANCER

The New England Journal of Medicine RADIAL SCARS IN BENIGN BREAST-BIOPSY SPECIMENS AND THE RISK OF BREAST CANCER RADIAL SCARS IN BENIGN BREAST-BIOPSY SPECIMENS AND THE RISK OF BREAST CANCER TIMOTHY W. JACOBS, M.D., CELIA BYRNE, PH.D., GRAHAM COLDITZ, M.D., JAMES L. CONNOLLY, M.D., AND STUART J. SCHNITT, M.D. ABSTRACT

More information

My Personalized Breast Cancer Worksheet

My Personalized Breast Cancer Worksheet My Personalized Breast Cancer Worksheet KNOW For Early-Stage Breast Cancer. No Questions. Only Results. No two tumors are alike. What are the characteristics of your breast cancer and how will that effect

More information

Chemo-endocrine prevention of breast cancer

Chemo-endocrine prevention of breast cancer Chemo-endocrine prevention of breast cancer Andrea DeCensi, MD Division of Medical Oncology Ospedali Galliera, Genova; Division of Cancer Prevention and Genetics, European Institute of Oncology, Milano;

More information

Papillary Lesions of the Breast: WHO Update

Papillary Lesions of the Breast: WHO Update Papillary Lesions of the Breast: WHO Update Stuart J. Schnitt, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA, USA Papillary Lesions of the Breast

More information

Management of B3 lesions

Management of B3 lesions Management of B3 lesions Pathological view Abeer Shaaban Queen Elizabeth Hospital Birmingham FEA AIDP B3 lesions In situ Lobular neoplasia Papilloma Radial scar Fibroaepithelial lesion Mucocoele like lesion

More information

RMF BREAST CARE MANAGEMENT ALGORITHM

RMF BREAST CARE MANAGEMENT ALGORITHM RMF BREAST CARE MANAGEMENT ALGORITHM IMPROVING BREAST PATIENT SAFETY 2003 Risk Management Foundation of the Harvard Medical Instititutions page 1 Improving Breast Patient Safety Failure to diagnose breast

More information

// Award Number: DAMD TITLE: Markers of Breast Cancer Risk in Women with Benign Breast Disease PRINCIPAL INVESTIGATOR:

// Award Number: DAMD TITLE: Markers of Breast Cancer Risk in Women with Benign Breast Disease PRINCIPAL INVESTIGATOR: AD Award Number: DAMD17-00-1-0623 TITLE: Markers of Breast Cancer Risk in Women with Benign Breast Disease PRINCIPAL INVESTIGATOR: Margaret Mandelson, Ph.D. CONTRACTING ORGANIZATION: Group Health Cooperative

More information

Mammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand

Mammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand Mammographic imaging of nonpalpable breast lesions Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand Introduction Contents Mammographic signs of nonpalpable breast cancer

More information

Prophylactic Mastectomy

Prophylactic Mastectomy Prophylactic Mastectomy Policy Number: Original Effective Date: MM.06.010 01/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 09/01/2015 Section: Surgery Place(s) of Service:

More information

Interval Cancers in BreastScreen Aotearoa

Interval Cancers in BreastScreen Aotearoa Interval Cancers in BreastScreen Aotearoa 2008 2009 Released 2018 nsu.govt.nz Citation: National Screening Unit. 2018. Interval Cancers in BreastScreen Aotearoa 2008 2009. Wellington: Ministry of Health.

More information

GOALS AND OBJECTIVES BREAST PATHOLOGY

GOALS AND OBJECTIVES BREAST PATHOLOGY GOALS AND OBJECTIVES BREAST PATHOLOGY LEVEL: PGY2, PGY3, PGY5 A number of these rotations are introductory in nature, as they are major subspecialties, and are followed by two more blocks in PGY-3, during

More information

Minimizing Errors in Diagnostic Pathology

Minimizing Errors in Diagnostic Pathology Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine-Jacksonville Medical Director, Shands Jacksonville Breast Health Center

More information

A Decade of Change: An Institutional Experience with Breast Surgery in 1995 and 2005

A Decade of Change: An Institutional Experience with Breast Surgery in 1995 and 2005 ORIGINAL RESEARCH A Decade of Change: An Institutional Experience with Breast Surgery in 1995 and 2005 Amber A. Guth 1, Beth Ann Shanker 1, Daniel F. Roses 1, Deborah Axelrod 1, Baljit Singh 2, Hildegard

More information

Review Article. ISSN: (Print) ISSN: (Online)

Review Article. ISSN: (Print) ISSN: (Online) Scholars International Journal of Obstetrics and Gynecology Abbreviated key title: Sch. Int. J. Obstet. Gynec. A Publication by Scholars Middle East Publishers Dubai, United Arab Emirates ISSN: 2616-8235

More information

Contents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ

Contents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ Contents 1 The Windows of Susceptibility to Breast Cancer... 1 1.1 Introduction... 1 1.2 Risk Factor and Etiological Agents... 2 1.3 The Concept of the Windows of Susceptibility to Carcinogenesis... 5

More information

Multiple Fibroadenomas Harboring Carcinoma in Situ in a Woman with a Familty History of Breast/ Ovarian Cancer

Multiple Fibroadenomas Harboring Carcinoma in Situ in a Woman with a Familty History of Breast/ Ovarian Cancer Multiple Fibroadenomas Harboring Carcinoma in Situ in a Woman with a Familty History of Breast/ Ovarian Cancer A Kuijper SS Preisler-Adams FD Rahusen JJP Gille E van der Wall PJ van Diest J Clin Pathol

More information

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers 29th Annual International Conference Advances in the Application of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells 25 th -27t h June, 2012, Mykonos, Greece Epithelial Columnar

More information

Radiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging

Radiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Radiation and DCIS The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Einsley-Marie Janowski, MD, PhD Assistant Professor Department of Radiation Oncology

More information

CLINICAL GUIDELINES. Screening Mammography Guidelines

CLINICAL GUIDELINES. Screening Mammography Guidelines CLINICAL GUIDELINES Screening Mammography Guidelines Paula George, M.D. and C. Todd Cunningham, M.D., Karen F. Goodhope, M.D., Valerie C. Reichert, M.D. Hayley Sheldon, M.D., Michelle Walters, D.O. 2/17/2016

More information

Diagnostic accuracy of ultrasonography-guided core needle biopsy for breast lesions

Diagnostic accuracy of ultrasonography-guided core needle biopsy for breast lesions Singapore Med J 01; 5(1) 40 Diagnostic accuracy of ultrasonography-guided core needle biopsy for breast lesions Wiratkapun Cl, MD, Treesit T1, MD, Wibulpolprasert E1, MD, Lertsithichai P, MD, MSc INTRODUCTION

More information

TRIAL SYNOPSIS LORIS. The Low Risk DCIS Trial. Chief Investigator. Miss Adele Francis

TRIAL SYNOPSIS LORIS. The Low Risk DCIS Trial. Chief Investigator. Miss Adele Francis TRIAL SYNOPSIS LORIS Chief Investigator The Low Risk DCIS Trial Miss Adele Francis ISRCTN No. 27544579 Sponsor University of Birmingham, United Kingdom Trial Design Objectives of Feasibility Study A multi-centre,

More information

The management of B3 lesions with emphasis on lobular neoplasia

The management of B3 lesions with emphasis on lobular neoplasia The management of B3 lesions with emphasis on lobular neoplasia Abeer Shaaban Queen Elizabeth Hospital Birmingham NHSBSP core biopsy categories B1 - Normal B2 - Benign B3 Uncertain malignant potential

More information

COMPANION MEETING BREAST. Auditorium 11:15 1:00 am. Convenor: A/Professor Gelareh Farshid, SA Pathology, SA

COMPANION MEETING BREAST. Auditorium 11:15 1:00 am. Convenor: A/Professor Gelareh Farshid, SA Pathology, SA Australasian Division of the International Academy of Pathology Limited ABN 73 008 593 815 36 TH Annual Scientific Meeting Darling Harbour Convention Centre, Sydney, Australia June 3-5, 2011 COMPANION

More information

Image guided core biopsies:

Image guided core biopsies: Recommendations on the Surgical, Radiologic and Pathologic Approaches to Breast Disease: Using best practices based on multidisciplinary methodologies developed through the Allina Breast Committee. Image

More information

Interpretation of Breast Pathology in the Era of Minimally Invasive Procedures

Interpretation of Breast Pathology in the Era of Minimally Invasive Procedures Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine Jacksonville Medical Director, UF Health Breast Center Chief of Pathology

More information

Papillary Lesions of the Breast

Papillary Lesions of the Breast Papillary Lesions of the Breast Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical Center and Harvard Medical School

More information

Palpable Breast Lesions Cytomorphological Analysis and Scoring System with Histopatholgical Correlation

Palpable Breast Lesions Cytomorphological Analysis and Scoring System with Histopatholgical Correlation IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 10 Ver. III (October. 2016), PP 25-29 www.iosrjournals.org Palpable Breast Lesions Cytomorphological

More information

Multicenter Evaluation of the Breast Lesion Excision System, a Percutaneous, Vacuum-Assisted, Intact-Specimen Breast Biopsy Device

Multicenter Evaluation of the Breast Lesion Excision System, a Percutaneous, Vacuum-Assisted, Intact-Specimen Breast Biopsy Device 945 Multicenter Evaluation of the Breast Lesion Excision System, a Percutaneous, Vacuum-Assisted, Intact-Specimen Breast Biopsy Device Angela Sie, MD 1 David C. Bryan, MD 2 Victor Gaines, MD 3 Larry K.

More information

Mammo-50 Eligibility Queries

Mammo-50 Eligibility Queries Mammo-50 Eligibility Queries Are patients who have received either neo-adjuvant or adjuvant chemo, radiotherapy or been part of another trial, ie OPTIMA, FAST FORWARD excluded from entry? Any patients

More information

Is Lobular Carcinoma In Situ as a Component of Breast Carcinoma a Risk Factor for Local Failure after Breast-Conserving Therapy?

Is Lobular Carcinoma In Situ as a Component of Breast Carcinoma a Risk Factor for Local Failure after Breast-Conserving Therapy? 28 Is Lobular Carcinoma In Situ as a Component of Breast Carcinoma a Risk Factor for Local Failure after Breast-Conserving Therapy? Results of a Matched Pair Analysis Merav A. Ben-David, M.D. 1 Celina

More information

CNB vs Surgical Excision

CNB vs Surgical Excision Update on Core Needle Biopsy of Non-palpable Breast Lesions Nour Sneige, M.D. UT MD Anderson Cancer Center Houston, Tx Image-Guided CNB of Breast Lesions An alternative to surgical biospy CNB vs Surgical

More information

Racial/Ethnic Disparities in Second Breast Lesions after DCIS. Graham A. Colditz, MD DrPH Kevin Garza Ying Liu, MD PhD Rosy Luo, PhD Yu Tao, PhD

Racial/Ethnic Disparities in Second Breast Lesions after DCIS. Graham A. Colditz, MD DrPH Kevin Garza Ying Liu, MD PhD Rosy Luo, PhD Yu Tao, PhD Racial/Ethnic Disparities in Second Breast Lesions after DCIS Graham A. Colditz, MD DrPH Kevin Garza Ying Liu, MD PhD Rosy Luo, PhD Yu Tao, PhD Why DCIS? DCIS over 45,000 cases per year SEER 18 Cancer

More information

ORIGINAL ARTICLE INTRODUCTION

ORIGINAL ARTICLE INTRODUCTION The Breast (2003) 12, 314 319 0960-9776/03/$ - see front matter r 2003 Elsevier Ltd. All rights reserved. doi:10.1016/s0960-9776(03)00102-4 ORIGINAL ARTICLE Fine-needle aspiration cytology in nonpalpable

More information

CONTENTS NOTE TO THE READER...1 LIST OF PARTICIPANTS...3

CONTENTS NOTE TO THE READER...1 LIST OF PARTICIPANTS...3 CONTENTS NOTE TO THE READER....1 LIST OF PARTICIPANTS....3 WORKING PROCEDURES...7 A. GENERAL PRINCIPLES AND PROCEDURES...7 1. Background....7 2. Scope....7 3. Objectives....8 4. Meeting participants...8

More information

Eligibility criteria for prophylactic treatment allowance

Eligibility criteria for prophylactic treatment allowance Eligibility criteria for prophylactic treatment allowance Southern Cross will only pay the prophylactic treatment allowance for the following healthcare services when the applicable eligibility criteria

More information

Vacuum-assisted breast biopsy using computer-aided 3.0 T- MRI guidance: diagnostic performance in 173 lesions

Vacuum-assisted breast biopsy using computer-aided 3.0 T- MRI guidance: diagnostic performance in 173 lesions Vacuum-assisted breast biopsy using computer-aided 3.0 T- MRI guidance: diagnostic performance in 173 lesions Poster No.: C-2870 Congress: ECR 2017 Type: Scientific Exhibit Authors: A. Pozzetto, L. Camera,

More information

Advocating Nonsurgical Management of Patients With Small, Incidental Radial Scars at the Time of Needle Core Biopsy. A Study of 77 Cases

Advocating Nonsurgical Management of Patients With Small, Incidental Radial Scars at the Time of Needle Core Biopsy. A Study of 77 Cases Advocating Nonsurgical Management of Patients With Small, Incidental Radial Scars at the Time of Needle Core Biopsy A Study of 77 Cases Cathleen Matrai, MD; Timothy M. D Alfonso, MD; Lindsay Pharmer, MD;

More information

Papillary Lesions of the Breast

Papillary Lesions of the Breast Papillary Lesions of the Breast Texas Society of Pathologists 2013 Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical

More information

NATIONAL GUIDELINE CLEARINGHOUSE (NGC) GUIDELINE SYNTHESIS SCREENING FOR BREAST CANCER

NATIONAL GUIDELINE CLEARINGHOUSE (NGC) GUIDELINE SYNTHESIS SCREENING FOR BREAST CANCER NATIONAL GUIDELINE CLEARINGHOUSE (NGC) GUIDELINE SYNTHESIS SCREENING FOR BREAST CANCER Guidelines 1. American Cancer Society (ACS). (1) ACS guidelines for breast cancer screening: update 2003. (2) American

More information